Oracle has lost more than half its value from last year's peak, yet the investment case hinges on whether its record $638 billion backlog can offset mounting debt and AI customer concentration risks.
Oracle has lost more than half its value from last year's peak, yet the investment case hinges on whether its record $638 billion backlog can offset mounting debt and AI customer concentration risks.

Oracle has lost more than half its value from last year's peak, yet the investment case hinges on whether its record $638 billion backlog can offset mounting debt and AI customer concentration risks.
Oracle stock has plunged 56% from its $345 September peak to about $142, as investors weigh a $638 billion backlog against $129 billion in debt and concerns over its AI customer base.
"Oracle's backlog provides exceptional visibility into our future revenue growth," Hilary Maxson, chief financial officer at Oracle, said on the company's Q4 earnings call.
Cloud infrastructure revenue jumped 93% to $5.8 billion in the fiscal fourth quarter, with total revenue up 21% to $19.2 billion. Remaining performance obligations surged $85 billion to $638 billion, one of the largest backlogs in the industry. Management guided Q1 revenue growth of 27% to 29% and annual revenue of about $90 billion, above the $89 billion consensus.
The stock's decline reflects investor concern that Oracle's expansion — $48 billion in capital expenditure this year and $70 billion next year — will require substantial debt and equity raises. The company plans to raise $40 billion in combined debt and equity this year, with total debt reaching $129 billion and interest payments of $1.4 billion in the last quarter alone. S&P Global downgraded Oracle to BBB in June.
The bear case extends beyond the balance sheet. Oracle's heavy exposure to OpenAI, whose revenue growth has slowed, and broader concerns about an AI bubble — flagged by investor Michael Burry — have compounded selling pressure. The stock trades at a forward price-to-earnings ratio of 18, below the sector median of 22, which some analysts argue makes it undervalued.
Wall Street remains broadly bullish. UBS has a price target of $245, Wedbush $240, Bernstein $325, Barclays $250, and Moffett Nathanson $325. The consensus target sits near $246, implying roughly 70% upside from current levels.
Technical risk looms
The weekly chart shows a giant head-and-shoulders pattern with a neckline at $118.90. The stock remains below its 50-day exponential moving average, and a break below the neckline could accelerate selling toward lower support levels. Conversely, holding $118.90 on strong earnings follow-through could trigger a sharp short-covering rally.
Backlog vs. the balance sheet
Oracle's backlog now rivals Microsoft's $678 billion in commercial RPO, despite Microsoft's market cap being roughly eight times larger at $3.57 trillion versus Oracle's $434 billion. Microsoft trades at a forward P/E of 27, while Oracle's forward multiple of 19 is markedly cheaper. IBM, by contrast, grew Q2 revenue just 1.1% with an AI book of business near $12.5 billion — orders of magnitude smaller than Oracle's backlog.
Oracle's partnership with Amazon Web Services, which made Oracle Exadata Database Service generally available on AWS's Exascale Infrastructure across 22 regions, adds another growth vector. The company signed $67 billion in AI infrastructure contracts in a single quarter, with global GPU utilization at 97.5%.
The key test comes in Q1 FY2027, when Oracle must demonstrate it can convert its backlog into revenue at forecast margins while managing rising interest costs. Management projects OCI reaching $144 billion by fiscal 2030, and CFO Maxson expects steady-state return on invested capital "in the high 20s." If capacity delivery approaches the 1 gigawatt target management flagged, the bull case for a return toward $200-plus strengthens. If free cash flow remains deeply negative through fiscal 2028 without visible RPO conversion, the stock could test the $118.90 neckline.
This article is for informational purposes only and does not constitute investment advice.